fda warning letters compounded semaglutide telehealth 2024 2025 issued 25 to companies for false and misleading claims about GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA telehealth crackdown highlights role

In this context, the introduction of retatrutide, a triple-hormone receptor agonist, has generated a lot of excitement in the medical community

Always consult with your healthcare provider before starting, changing, or adjusting any medication dosage

95% of our clients pay $0 out of pocket

However, Hims & Hers pointed out to Fortune that the FDA had noted, many of the adverse events reported for compounded products appear to be consistent with adverse events related to the FDA-approved versions of these products. Hims & Hers did include a disclaimer in its ad saying its compounded medications arent FDA-approved, albeit briefly and in minuscule font

Method of Treatment : Specific indications (diseases) that can be treated with the active ingredient alone Method of Treatment and Combination : Specific indications (diseases) that can be treated by combining two active ingredients

The trials indicated that all doses of tirzepatide resulted in greater weight loss and enhanced glycemic control in comparison to placebo